High rates of Staphylococcus aureus USA400 infection, Northern Canada.
about
Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in Northern Saskatchewan, CanadaVirulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)Community-associated methicillin-resistant Staphylococcus aureus infection: Literature review and clinical update.Emergence of new CMRSA7/USA400 methicillin-resistant Staphylococcus aureus spa types in Alberta, Canada, from 2005 to 2012Impact of agr dysfunction on virulence profiles and infections associated with a novel methicillin-resistant Staphylococcus aureus (MRSA) variant of the lineage ST1-SCCmec IV.MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000-2006.A cross sectional study of animal and human colonization with Methicillin-Resistant Staphylococcus aureus (MRSA) in an Aboriginal communityPolyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance periodPopulation-based study of the increased incidence of skin and soft tissue infections and associated antimicrobial use.Draft Genome Sequence of Streptococcus pyogenes Strain 06BA18369, a Human Pathogen Associated with Skin and Soft Tissue Infections in Northern CanadaDraft Genome Sequence of Methicillin-Susceptible Staphylococcus aureus Strain 06BA18369, a Pathogen Associated with Skin and Soft Tissue Infections in Northern Saskatchewan, CanadaCommunity-associated methicillin-resistant Staphylococcus aureus in northwest Ontario: A five-year report of incidence and antibiotic resistance.Cutaneous Immune Defenses Against Staphylococcus aureus Infections.Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus.Comparing the epidemiology of hospital-acquired methicillin-resistant Staphylococcus aureus clone groups in Alberta, Canada.Complete genome sequence of community-associated methicillin-resistant Staphylococcus aureus (strain USA400-0051), a prototype of the USA400 clone.Distribution of the Most Prevalent Spa Types among Clinical Isolates of Methicillin-Resistant and -Susceptible Staphylococcus aureus around the World: A Review.
P2860
Q21257289-5F4E7F20-AA1D-484F-B4D3-BAA6ACE4A72BQ33874939-DFE1DFA1-C1A9-4DDC-8933-C5FA351B0F80Q33897606-80F9ECF6-8EF7-4BFE-B730-0622F8A0964CQ33900198-820C263A-30AA-4E7D-88C8-5A1D7E9E1189Q34691308-AD414CD0-DCFD-482B-A10E-E0687F14E071Q35845890-DA802B4D-A21C-445D-96B2-FF57B2A0FC3BQ36080639-A3BF98DC-01B4-4559-8F44-A3F079E64066Q36323321-7194964E-F61D-4E66-BE5D-BC804E348B69Q36396110-1F2A3730-8372-4268-90BC-FEB1465900FFQ36962928-6C3AE451-7CBE-4016-AA35-90889B1BAFD5Q36962937-752ED7FD-8E97-49B1-BC31-DBD8283EDD68Q38178256-9834DF06-FF52-49B5-809C-0D9BF81B3183Q38524810-D3FE98D4-B639-4C73-BAEF-C0F5C42168CAQ40098505-9F50E4D2-64DF-4F80-A24B-B32888403FF2Q40765928-39E09D83-6633-4099-B371-99A3FE6ABBEAQ44451787-A49627AE-9A66-4A70-B28A-FFE6C770AE3DQ50327973-E559FCE4-50A1-4180-BBD5-3D07BBDBAF5A
P2860
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
@ast
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
@en
type
label
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
@ast
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
@en
prefLabel
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
@ast
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
@en
P2093
P2860
P356
P1476
High rates of Staphylococcus aureus USA400 infection, Northern Canada.
@en
P2093
Brian Quinn
George R Golding
James Irvine
Mandiangu Nsungu
Marianna Ofner-Agostini
Michael R Mulvey
Mohammad Khan
Northern Antibiotic Resistance Partnership
Paul N Levett
Ryan R McDonald
P2860
P304
P356
10.3201/EID1704.100482
P577
2011-04-01T00:00:00Z